TEVA-SUMATRIPTAN
TEVA CANADA LIMITED
Quick answers
Is there a shortage of TEVA-SUMATRIPTAN in Canada?
No. There is no current shortage of TEVA-SUMATRIPTAN 100MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
IMITREX TAB 100MG
GLAXO CANADA INC
IMITREX DF - TAB 100MG
GLAXOSMITHKLINE INC
RATIO-SUMATRIPTAN
RATIOPHARM INC DIVISION OF TEVA CANADA LIMITED
RIVA-SUMATRIPTAN
LABORATOIRE RIVA INC.
Q-SUMATRIPTAN
QD PHARMACEUTICALS ULC
NTP-SUMATRIPTAN DF
TEVA CANADA LIMITED
DIN
02239367
Strength
100MG
Dosage Form
Tablet
Route
Oral
Active Ingredient
SUMATRIPTAN (SUMATRIPTAN SUCCINATE)
See all SUMATRIPTAN (SUMATRIPTAN SUCCINATE) products →Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646